Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
MLSS

MLSS - Milestone Scientific Inc Stock Price, Fair Value and News

$0.29-0.01 (-3.33%)
Market Closed

9/100

MLSS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

9/100

MLSS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.24

Target 3M

$0.27

Target 6M

$0.26

MLSS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MLSS Price Action

Last 7 days

7.4%

Last 90 days

-30.9%

Trailing 12 Months

-77.5%

MLSS RSI Chart

MLSS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

MLSS Valuation

Market Cap

22.8M

Price/Earnings (Trailing)

-3.42

Price/Sales (Trailing)

2.55

EV/EBITDA

-3.26

Price/Free Cashflow

-6.91

MLSS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.24

Target 3M

$0.27

Target 6M

$0.26

MLSS Fundamentals

MLSS Revenue

Revenue (TTM)

8.9M

Rev. Growth (Yr)

-6.11%

Rev. Growth (Qtr)

1.58%

MLSS Earnings

Earnings (TTM)

-6.7M

Earnings Growth (Yr)

21.03%

Earnings Growth (Qtr)

22.19%

MLSS Profitability

EBT Margin

-74.66%

Return on Equity

-261.52%

Return on Assets

-78.57%

Free Cashflow Yield

-14.47%

MLSS Investor Care

Shares Dilution (1Y)

0.95%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20258.6M9.1M8.9M0
20249.5M8.4M8.9M8.6M
20238.7M10.0M9.8M9.8M
202210.1M9.3M9.4M8.8M
20216.6M8.8M9.7M10.3M
20208.3M6.2M5.5M5.4M
20199.7M9.6M9.8M8.4M
20189.4M9.3M8.1M9.6M
201710.7M10.8M10.5M11.3M
201610.3M10.9M11.6M10.6M
201510.5M9.7M9.7M9.5M
201410.1M10.4M10.5M10.3M
20139.2M9.2M9.5M10.0M
20127.9M7.7M8.1M8.6M
20119.4M9.1M8.7M8.4M
20100009.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About Milestone Scientific Inc

MLSS
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
 CEO
 WEBSITEmilestonescientific.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES20

Milestone Scientific Inc Frequently Asked Questions

MLSS is the stock ticker symbol of Milestone Scientific Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Milestone Scientific Inc is 22.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check MLSS's fair value in chart for subscribers.

The fair value guage provides a quick view whether MLSS is over valued or under valued. Whether Milestone Scientific Inc is cheap or expensive depends on the assumptions which impact Milestone Scientific Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MLSS.

As of Wed Jan 28 2026, MLSS's PE ratio (Price to Earnings) is -3.42 and Price to Sales (PS) ratio is 2.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MLSS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Milestone Scientific Inc has provided -0.163 (multiply by 100 for percentage) rate of return.